Share Price and Basic Stock Data
Last Updated: November 20, 2025, 9:15 pm
| PEG Ratio | 12.30 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Aether Industries Ltd operates in the specialty chemicals sector, focusing on the manufacture of various chemical products. As of its latest reported figures, the company’s stock price stood at ₹896, with a market capitalization of ₹11,885 Cr. Revenue from operations for the financial year ending March 2025 was ₹789 Cr, reflecting a notable increase from ₹651 Cr in March 2023. Aether’s revenue trajectory shows resilience, with a trailing twelve-month revenue of ₹851 Cr. Quarterly sales patterns indicate fluctuations, with a high of ₹196 Cr in September 2024 and a dip to ₹115 Cr in March 2024. This volatility may be attributed to market conditions or seasonal effects impacting demand. The operating profit margin (OPM) for the latest quarter was 32%, which aligns with industry standards, indicating solid operational efficiency. Overall, Aether’s revenue growth trajectory, despite recent quarterly fluctuations, showcases its potential within the specialty chemicals market.
Profitability and Efficiency Metrics
Aether Industries reported a net profit of ₹152 Cr for the financial year ending March 2025, up from ₹130 Cr in March 2023. The company’s net profit margin stood at 18.88%, indicating effective cost management and pricing strategies. The operating profit for the same period was ₹225 Cr, with an operating profit margin of 29%, demonstrating strong operational efficiency. However, the return on equity (ROE) was recorded at 7.11%, which is relatively low compared to industry peers, suggesting room for improvement in generating returns for shareholders. The cash conversion cycle (CCC) was reported at 388 days, indicating potential inefficiencies in managing working capital. While the interest coverage ratio (ICR) of 21.87x reflects a robust ability to cover interest expenses, Aether’s efficiency metrics suggest that while profitability is strong, operational and working capital management could benefit from further optimization.
Balance Sheet Strength and Financial Ratios
Aether Industries maintains a strong balance sheet, with no long-term borrowings reported, and total debt to equity ratio at 0.08x, indicating minimal leverage. The company’s current ratio was recorded at 3.25, significantly higher than the typical industry benchmark of 1.5, suggesting excellent liquidity. Book value per share stood at ₹167.88, reflecting solid shareholder equity. The price-to-book value (P/BV) ratio was reported at 4.95x, which may indicate that the stock is trading at a premium relative to its book value. Furthermore, the return on capital employed (ROCE) was 10.36%, showcasing effective utilization of capital in generating profits. However, the decline in the return on assets (ROA) to 5.99% highlights a potential area for improvement in asset efficiency. Overall, Aether’s financial ratios indicate a company with a strong liquidity position but suggest that greater efficiency in asset utilization could enhance profitability further.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Aether Industries indicates a strong promoter presence, holding 74.99% of the company’s equity as of June 2025. This level of promoter ownership may signal confidence in the company’s long-term growth prospects. Foreign institutional investors (FIIs) accounted for 4.64%, while domestic institutional investors (DIIs) held 12.97%, reflecting moderate institutional interest. The number of shareholders increased to 73,806, up from 64,034 in March 2025, indicating growing retail interest. However, the gradual decline in promoter shareholding from 87.07% in December 2022 to the current level may raise concerns regarding potential dilution of control. Additionally, the public holding increased to 7.39%, suggesting a diversification of shareholder base. Overall, while the strong promoter holding is a positive indicator, the changing dynamics of shareholding require monitoring to ensure sustained investor confidence.
Outlook, Risks, and Final Insight
Aether Industries faces both opportunities and challenges in its future growth trajectory. The company’s strong revenue growth and solid profitability metrics suggest a positive outlook, particularly if it can optimize its working capital management to improve its CCC and ROE. However, the volatility in quarterly sales and the declining trend in promoter shareholding pose risks that could affect investor sentiment. Additionally, potential fluctuations in raw material prices and global supply chain disruptions may impact operational stability. Aether must navigate these challenges while leveraging its strong liquidity and operational efficiencies to capitalize on market opportunities. Should the company enhance its asset utilization and maintain robust profit margins, it could see improved returns for shareholders. Conversely, failure to address efficiency and market volatility could hinder its growth potential. Aether’s ability to adapt and respond to these dynamics will be critical for its long-term success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Aether Industries Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 430 Cr. | 47.0 | 86.7/42.6 | 26.7 | 20.5 | 0.85 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 35.8 Cr. | 73.0 | 103/56.0 | 17.2 | 89.6 | 1.37 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 44.9 Cr. | 661 | 988/600 | 20.7 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,717 Cr. | 82.0 | 111/78.0 | 24.6 | 22.0 | 0.61 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 663 Cr. | 266 | 453/241 | 23.8 | 93.8 | 0.94 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,962.80 Cr | 744.41 | 64.06 | 182.93 | 0.42% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 160 | 140 | 167 | 184 | 161 | 164 | 155 | 115 | 180 | 196 | 197 | 215 | 214 |
| Expenses | 118 | 103 | 120 | 124 | 116 | 118 | 124 | 106 | 137 | 142 | 138 | 147 | 146 |
| Operating Profit | 42 | 37 | 47 | 60 | 45 | 46 | 31 | 9 | 43 | 55 | 60 | 67 | 69 |
| OPM % | 27% | 26% | 28% | 32% | 28% | 28% | 20% | 8% | 24% | 28% | 30% | 31% | 32% |
| Other Income | 6 | 6 | 3 | 1 | 3 | 15 | 6 | 6 | 9 | 9 | 11 | 3 | 1 |
| Interest | 3 | 1 | 0 | 1 | 1 | 2 | 2 | 4 | 3 | 2 | 3 | 2 | 3 |
| Depreciation | 5 | 5 | 6 | 7 | 9 | 10 | 10 | 10 | 10 | 11 | 10 | 12 | 13 |
| Profit before tax | 41 | 37 | 44 | 52 | 37 | 50 | 25 | 2 | 40 | 52 | 57 | 56 | 53 |
| Tax % | 26% | 27% | 20% | 28% | 18% | 24% | 25% | 40% | 24% | 26% | 29% | 23% | 24% |
| Net Profit | 31 | 27 | 35 | 38 | 30 | 38 | 19 | 1 | 30 | 38 | 41 | 43 | 40 |
| EPS in Rs | 2.46 | 2.19 | 2.81 | 3.02 | 2.28 | 2.85 | 1.44 | 0.08 | 2.28 | 2.87 | 3.08 | 3.24 | 3.03 |
Last Updated: August 1, 2025, 8:20 am
Below is a detailed analysis of the quarterly data for Aether Industries Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 214.00 Cr.. The value appears to be declining and may need further review. It has decreased from 215.00 Cr. (Mar 2025) to 214.00 Cr., marking a decrease of 1.00 Cr..
- For Expenses, as of Jun 2025, the value is 146.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 147.00 Cr. (Mar 2025) to 146.00 Cr., marking a decrease of 1.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 69.00 Cr.. The value appears strong and on an upward trend. It has increased from 67.00 Cr. (Mar 2025) to 69.00 Cr., marking an increase of 2.00 Cr..
- For OPM %, as of Jun 2025, the value is 32.00%. The value appears strong and on an upward trend. It has increased from 31.00% (Mar 2025) to 32.00%, marking an increase of 1.00%.
- For Other Income, as of Jun 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 2.00 Cr..
- For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Mar 2025) to 3.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 13.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 12.00 Cr. (Mar 2025) to 13.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 53.00 Cr.. The value appears to be declining and may need further review. It has decreased from 56.00 Cr. (Mar 2025) to 53.00 Cr., marking a decrease of 3.00 Cr..
- For Tax %, as of Jun 2025, the value is 24.00%. The value appears to be increasing, which may not be favorable. It has increased from 23.00% (Mar 2025) to 24.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Mar 2025) to 40.00 Cr., marking a decrease of 3.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.03. The value appears to be declining and may need further review. It has decreased from 3.24 (Mar 2025) to 3.03, marking a decrease of 0.21.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 4:02 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 1 | 0 | 24 | 109 | 201 | 302 | 450 | 590 | 651 | 596 | 789 | 851 |
| Expenses | 1 | 3 | 1 | 22 | 85 | 154 | 230 | 338 | 422 | 465 | 464 | 563 | 584 |
| Operating Profit | -1 | -2 | -1 | 2 | 23 | 48 | 72 | 112 | 168 | 186 | 131 | 225 | 267 |
| OPM % | -252% | -194% | 10% | 21% | 24% | 24% | 25% | 28% | 29% | 22% | 29% | 31% | |
| Other Income | 3 | 4 | 1 | 0 | 0 | 2 | 2 | 4 | 7 | 17 | 30 | 32 | 22 |
| Interest | 1 | 1 | 0 | 1 | 9 | 11 | 9 | 11 | 13 | 5 | 9 | 10 | 11 |
| Depreciation | 0 | 0 | 0 | 1 | 5 | 6 | 8 | 11 | 15 | 23 | 39 | 43 | 50 |
| Profit before tax | 0 | 0 | 0 | 1 | 9 | 33 | 57 | 94 | 146 | 174 | 114 | 205 | 228 |
| Tax % | 39% | 27% | 31% | 300% | 17% | 28% | 29% | 24% | 26% | 25% | 23% | 26% | |
| Net Profit | 0 | 0 | 0 | -1 | 8 | 23 | 40 | 71 | 109 | 130 | 88 | 152 | 167 |
| EPS in Rs | 0.14 | 0.12 | 0.11 | -1.27 | 9.08 | 27.27 | 46.68 | 70.43 | 9.67 | 10.47 | 6.65 | 11.47 | 12.64 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 900.00% | 187.50% | 73.91% | 77.50% | 53.52% | 19.27% | -32.31% | 72.73% |
| Change in YoY Net Profit Growth (%) | 0.00% | -712.50% | -113.59% | 3.59% | -23.98% | -34.26% | -51.57% | 105.03% |
Aether Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 98% |
| 5 Years: | 21% |
| 3 Years: | 10% |
| TTM: | 34% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 57% |
| 5 Years: | 32% |
| 3 Years: | 14% |
| TTM: | 73% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -6% |
| 1 Year: | -20% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 11% |
| 3 Years: | 8% |
| Last Year: | 7% |
Last Updated: September 5, 2025, 2:06 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 94 | 4,358 | 167 | 88 | 87 | 76 | 88 | 101 | 145 | 141 | 122 | |
| Inventory Days | 52 | 9,733 | 629 | 149 | 133 | 166 | 141 | 221 | 301 | 411 | 377 | |
| Days Payable | 172 | 1,922 | 575 | 92 | 76 | 88 | 82 | 95 | 99 | 113 | 111 | |
| Cash Conversion Cycle | -25 | 12,169 | 220 | 144 | 144 | 153 | 147 | 227 | 348 | 439 | 388 | |
| Working Capital Days | -794 | 9,037 | -18 | 49 | 11 | 32 | 36 | 82 | 268 | 360 | 276 | |
| ROCE % | -1% | -0% | 2% | 14% | 28% | 32% | 33% | 30% | 18% | 8% | 10% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Magnum Midcap Fund | 3,266,269 | 1.81 | 288.67 | 3,266,269 | 2025-04-22 17:25:14 | 0% |
| SBI Magnum Global Fund | 3,100,000 | 4.21 | 273.98 | 3,100,000 | 2025-04-22 17:25:14 | 0% |
| SBI Multicap Fund | 1,590,220 | 0.96 | 140.54 | 1,590,220 | 2025-04-22 17:25:14 | 0% |
| SBI Healthcare Opportunities Fund | 1,400,000 | 5.09 | 123.73 | 1,400,000 | 2025-04-22 17:25:14 | 0% |
| SBI Conservative Hybrid Fund | 1,030,000 | 0.94 | 89.22 | 1,030,000 | 2025-04-22 17:25:14 | 0% |
| SBI Conservative Hybrid Fund - Div (Annual) | 1,030,000 | 0.94 | 89.22 | 1,030,000 | 2025-04-22 17:25:14 | 0% |
| SBI Conservative Hybrid Fund - Div (Monthly) | 1,030,000 | 0.94 | 89.22 | 1,030,000 | 2025-04-22 17:25:14 | 0% |
| Axis Small Cap Fund | 585,452 | 0.26 | 51.74 | 585,452 | 2025-04-22 17:25:14 | 0% |
| SBI Magnum Childrens Benefit Fund - Investment Plan | 440,000 | 2.42 | 38.89 | 440,000 | 2025-04-22 17:25:14 | 0% |
| SBI Equity Savings Fund | 435,960 | 0.99 | 38.53 | 435,960 | 2025-04-22 17:25:14 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 11.95 | 6.31 | 10.47 | 9.67 |
| Diluted EPS (Rs.) | 11.94 | 6.31 | 10.47 | 9.67 |
| Cash EPS (Rs.) | 15.34 | 9.21 | 12.34 | 11.04 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 167.88 | 155.66 | 99.96 | 34.33 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 167.88 | 155.66 | 99.96 | 34.33 |
| Revenue From Operations / Share (Rs.) | 63.25 | 45.13 | 52.29 | 52.36 |
| PBDIT / Share (Rs.) | 21.33 | 12.94 | 16.29 | 15.54 |
| PBIT / Share (Rs.) | 17.93 | 9.94 | 14.42 | 14.16 |
| PBT / Share (Rs.) | 16.06 | 8.26 | 14.01 | 13.00 |
| Net Profit / Share (Rs.) | 11.95 | 6.22 | 10.47 | 9.67 |
| NP After MI And SOA / Share (Rs.) | 11.95 | 6.22 | 10.47 | 9.67 |
| PBDIT Margin (%) | 33.71 | 28.66 | 31.15 | 29.67 |
| PBIT Margin (%) | 28.35 | 22.03 | 27.58 | 27.04 |
| PBT Margin (%) | 25.39 | 18.30 | 26.79 | 24.82 |
| Net Profit Margin (%) | 18.88 | 13.79 | 20.03 | 18.46 |
| NP After MI And SOA Margin (%) | 18.88 | 13.79 | 20.03 | 18.46 |
| Return on Networth / Equity (%) | 7.11 | 3.99 | 10.47 | 28.15 |
| Return on Capital Employeed (%) | 10.36 | 6.24 | 13.96 | 30.24 |
| Return On Assets (%) | 5.99 | 3.43 | 9.45 | 14.14 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.31 |
| Total Debt / Equity (X) | 0.08 | 0.08 | 0.00 | 0.73 |
| Asset Turnover Ratio (%) | 0.33 | 0.31 | 0.60 | 0.00 |
| Current Ratio (X) | 3.25 | 4.51 | 7.18 | 1.69 |
| Quick Ratio (X) | 2.11 | 3.32 | 4.54 | 1.02 |
| Inventory Turnover Ratio (X) | 2.27 | 1.27 | 1.84 | 0.00 |
| Interest Coverage Ratio (X) | 21.87 | 20.13 | 39.82 | 13.34 |
| Interest Coverage Ratio (Post Tax) (X) | 14.17 | 12.30 | 26.61 | 9.30 |
| Enterprise Value (Cr.) | 10957.01 | 9960.48 | 11572.59 | 0.00 |
| EV / Net Operating Revenue (X) | 13.06 | 16.65 | 17.77 | 0.00 |
| EV / EBITDA (X) | 38.74 | 58.09 | 57.06 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 13.13 | 17.30 | 17.93 | 0.00 |
| Price / BV (X) | 4.95 | 5.01 | 9.38 | 0.00 |
| Price / Net Operating Revenue (X) | 13.13 | 17.30 | 17.93 | 0.00 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.00 |
After reviewing the key financial ratios for Aether Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 11.95. This value is within the healthy range. It has increased from 6.31 (Mar 24) to 11.95, marking an increase of 5.64.
- For Diluted EPS (Rs.), as of Mar 25, the value is 11.94. This value is within the healthy range. It has increased from 6.31 (Mar 24) to 11.94, marking an increase of 5.63.
- For Cash EPS (Rs.), as of Mar 25, the value is 15.34. This value is within the healthy range. It has increased from 9.21 (Mar 24) to 15.34, marking an increase of 6.13.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 167.88. It has increased from 155.66 (Mar 24) to 167.88, marking an increase of 12.22.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 167.88. It has increased from 155.66 (Mar 24) to 167.88, marking an increase of 12.22.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 63.25. It has increased from 45.13 (Mar 24) to 63.25, marking an increase of 18.12.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 21.33. This value is within the healthy range. It has increased from 12.94 (Mar 24) to 21.33, marking an increase of 8.39.
- For PBIT / Share (Rs.), as of Mar 25, the value is 17.93. This value is within the healthy range. It has increased from 9.94 (Mar 24) to 17.93, marking an increase of 7.99.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.06. This value is within the healthy range. It has increased from 8.26 (Mar 24) to 16.06, marking an increase of 7.80.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 11.95. This value is within the healthy range. It has increased from 6.22 (Mar 24) to 11.95, marking an increase of 5.73.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 11.95. This value is within the healthy range. It has increased from 6.22 (Mar 24) to 11.95, marking an increase of 5.73.
- For PBDIT Margin (%), as of Mar 25, the value is 33.71. This value is within the healthy range. It has increased from 28.66 (Mar 24) to 33.71, marking an increase of 5.05.
- For PBIT Margin (%), as of Mar 25, the value is 28.35. This value exceeds the healthy maximum of 20. It has increased from 22.03 (Mar 24) to 28.35, marking an increase of 6.32.
- For PBT Margin (%), as of Mar 25, the value is 25.39. This value is within the healthy range. It has increased from 18.30 (Mar 24) to 25.39, marking an increase of 7.09.
- For Net Profit Margin (%), as of Mar 25, the value is 18.88. This value exceeds the healthy maximum of 10. It has increased from 13.79 (Mar 24) to 18.88, marking an increase of 5.09.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 18.88. This value is within the healthy range. It has increased from 13.79 (Mar 24) to 18.88, marking an increase of 5.09.
- For Return on Networth / Equity (%), as of Mar 25, the value is 7.11. This value is below the healthy minimum of 15. It has increased from 3.99 (Mar 24) to 7.11, marking an increase of 3.12.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.36. This value is within the healthy range. It has increased from 6.24 (Mar 24) to 10.36, marking an increase of 4.12.
- For Return On Assets (%), as of Mar 25, the value is 5.99. This value is within the healthy range. It has increased from 3.43 (Mar 24) to 5.99, marking an increase of 2.56.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.08. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.08.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.33. It has increased from 0.31 (Mar 24) to 0.33, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 3.25. This value exceeds the healthy maximum of 3. It has decreased from 4.51 (Mar 24) to 3.25, marking a decrease of 1.26.
- For Quick Ratio (X), as of Mar 25, the value is 2.11. This value exceeds the healthy maximum of 2. It has decreased from 3.32 (Mar 24) to 2.11, marking a decrease of 1.21.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.27. This value is below the healthy minimum of 4. It has increased from 1.27 (Mar 24) to 2.27, marking an increase of 1.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 21.87. This value is within the healthy range. It has increased from 20.13 (Mar 24) to 21.87, marking an increase of 1.74.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 14.17. This value is within the healthy range. It has increased from 12.30 (Mar 24) to 14.17, marking an increase of 1.87.
- For Enterprise Value (Cr.), as of Mar 25, the value is 10,957.01. It has increased from 9,960.48 (Mar 24) to 10,957.01, marking an increase of 996.53.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 13.06. This value exceeds the healthy maximum of 3. It has decreased from 16.65 (Mar 24) to 13.06, marking a decrease of 3.59.
- For EV / EBITDA (X), as of Mar 25, the value is 38.74. This value exceeds the healthy maximum of 15. It has decreased from 58.09 (Mar 24) to 38.74, marking a decrease of 19.35.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 13.13. This value exceeds the healthy maximum of 3. It has decreased from 17.30 (Mar 24) to 13.13, marking a decrease of 4.17.
- For Price / BV (X), as of Mar 25, the value is 4.95. This value exceeds the healthy maximum of 3. It has decreased from 5.01 (Mar 24) to 4.95, marking a decrease of 0.06.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 13.13. This value exceeds the healthy maximum of 3. It has decreased from 17.30 (Mar 24) to 13.13, marking a decrease of 4.17.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Aether Industries Ltd:
- Net Profit Margin: 18.88%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.36% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.11% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 14.17
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.11
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 67.7 (Industry average Stock P/E: 64.06)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.08
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 18.88%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Plot No. 8203, Surat Gujarat 394230 | info@aether.co.in http://www.aether.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kamalvijay Ramchandra Tulsian | Chairman & Non-Exe.Director |
| Mr. Ashwin Jayantilal Desai | Managing Director |
| Mr. Rohan Ashwin Desai | Whole Time Director |
| Dr. Aman Ashvin Desai | Whole Time Director |
| Ms. Purnima Ashwin Desai | Whole Time Director |
| Ms. Ishita Surendra Manjrekar | Non Executive Director |
| Mr. Arun Brijmohan Kanodiya | Ind. Non-Executive Director |
| Mr. Jeevan Lal Nagori | Ind. Non-Executive Director |
| Mr. Leja Satish Hattiangadi | Ind. Non-Executive Director |
| Dr. Amol Arvindrao Kulkarni | Ind. Non-Executive Director |
| Mr. Rajkumar Mangilal Borana | Ind. Non-Executive Director |
| Mr. Jitendra Popatlal Vakharia | Ind. Non-Executive Director |